| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.0008 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.002 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |